Carboxypeptidase U (TAFIa) activity is induced in vivo in ischemic stroke patients receiving thrombolytic therapy

thrombocytopenia and cerebral thrombosis after a single administration of unfractionated heparin. N Engl J Med 2003; 348: 1067–9. 7 Rauova L, Zhai L, KowalskaMA, Arepally GM, Cines DB, PonczM. Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications. Blood 2006; 107: 2346–53. 8 Polgar J, Eichler P, Greinacher A, Clemetson KJ. Adenosine diphosphate (ADP) and ADP receptor play a major role in platelet activation/aggregation induced by sera from heparin-induced thrombocytopenia patients. Blood 1998; 91: 549–54. 9 Prechel MM, McDonald MK, Jeske WP, Messmore HL, Walenga JM. Activation of platelets by heparin-induced thrombocytopenia antibodies in the serotonin release assay is not dependent on the presence of heparin. J Thromb Haemost 2005; 3: 2168–75. 10 Potzsch B, Keller M, Madlener K, Muller-Berghaus G. The use of heparinase improves the specificity of crossreactivity testing in heparininduced thrombocytopenia. Thromb Haemost 1996; 76: 1121. 11 Greinacher A, Michels I, Kiefel V, Mueller-Eckhardt C. A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia. Thromb Haemost 1991; 66: 734–6. 12 Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Evaluation of pretest clinical score (4 T s) for the diagnosis of heparininduced thrombocytopenia in two clinical settings. J Thromb Haemost 2006; 4: 759–65. 13 Capitano AM, Niewiarowski S, Rucinski B, Tuszynski GP, Cierniewski CS, Kornecki E. Interaction of platelet factor 4 with human platelets. Biochim Biophys Acta 1985; 839: 161–73. 14 Aster RH. Heparin-independent activation of platelets by HIT antibodies: a clue to the etiology of delayed thrombocytopenia/thrombosis in patients given heparin? J Thromb Haemost 2005; 3: 2166–7.